News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

DNAtrix, Inc. Awarded $10.8 Million Grant By The Cancer Prevention And Research Institute Of Texas


2/24/2014 8:02:38 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

HOUSTON--(BUSINESS WIRE)--DNAtrix Inc., a biotech company focusing on the development of oncolytic viruses for cancer, announced today that it has been awarded a product development grant for $10.8 million to fund the company’s clinical-stage program in glioblastoma—the most aggressive type of brain cancer. The grant from the Cancer Prevention and Research Institute of Texas (CPRIT) is entitled “Clinical development and commercialization of oncolytic adenovirus for treating malignant glioma.”

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES